Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 187
Filter
1.
Rev Fr Allergol (2009) ; 61(5): 366-370, 2021 Sep.
Article in French | MEDLINE | ID: mdl-34099963

ABSTRACT

Recurrent venom extracts shortages as well as the COVID-19 pandemic have prompted the SFA/Anaforcal Stinging Insects Task Force to develop recommendations on venom immunotherapy (VIT), in accordance with international guidelines, to be able to offer and maintain VIT to patients with life-threatening risks. How to diagnose allergy to hymenoptera venoms, indications and duration of VIT, maintenance intervals and doses, interchangeability of venom extracts and monitoring of patients on VIT have been adapted to this time of crisis, allowing clinicians to treat their patients with the most benefit and lowest constraint. These recommendations are temporary and will be reviewed after returning to a normal situation.

2.
Anaesthesist ; 67(12): 922-930, 2018 12.
Article in English | MEDLINE | ID: mdl-30338337

ABSTRACT

BACKGROUND: Dural puncture, paraesthesia and vascular puncture are the most common complications of epidural catheter insertion. Their association with variation in midline needle insertion depth is unknown. OBJECTIVE: This study evaluated the risk of dural and vascular punctures and the unwanted events paraesthesia and multiple skin punctures related to midline needle insertion depth. MATERIAL AND METHODS: A total of 14,503 epidural catheter insertions including lumbar (L1-L5; n = 5367), low thoracic (T7-T12, n = 8234) and upper thoracic (T1-T6, n = 902) insertions, were extracted from the German Network for Regional Anaesthesia registry between 2007 and 2015. The primary outcomes were compared with logistic regression and adjusted (adj) for confounders to determine the risk of complications/events. Results are presented as odds ratios (OR, [95% confidence interval]). MAIN RESULTS: Midline insertion depth depended on body mass index, sex, and spinal level. After adjusting for confounders increased puncture depth (cm) remained an independent risk factor for vascular puncture (adjOR 1.27 [1.09-1.47], p = 0.002) and multiple skin punctures (adjOR 1.25 [1.21-1.29], p < 0.001). In contrast, dural punctures occurred at significantly shallower depths (adjOR 0.73 [0.60-0.89], p = 0.002). Paraesthesia was unrelated to insertion depth. Body mass index and sex had no influence on paraesthesia, dural and vascular punctures. Thoracic epidural insertion was associated with a lower risk of vascular puncture than at lumbar sites (adjOR 0.39 [0.18-0.84], p = 0.02). CONCLUSION: Variation in midline insertion depth is an independent risk factor for epidural complications; however, variability precludes use of depth as a reliable guide to insertion in individual patients.


Subject(s)
Anesthesia, Epidural/adverse effects , Adult , Aged , Anesthesia, Epidural/instrumentation , Anesthesia, Epidural/statistics & numerical data , Anesthesia, Obstetrical , Catheterization , Female , Humans , Male , Middle Aged , Needles , Punctures/statistics & numerical data , Risk Factors
3.
J Clin Pharm Ther ; 43(3): 320-326, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29092096

ABSTRACT

WHAT IS KNOWN AND OBJECTIVE: With the increasing use of cancer chemotherapy agents, hypersensitivity reactions are commonly encountered. The allergic clinical symptoms are variable and unpredictable. The aim of this study was to identify the characteristics of hypersensitivity reactions and to assess the value of skin tests for platinum salts and pemetrexed in the treatment of patients with non-small cell lung cancers or malignant pleural mesothelioma. METHODS: A single-centre retrospective study was performed for 2 years. Patients treated with the drugs of interest for an advanced or metastatic non-small cell lung cancers or malignant pleural mesothelioma and who experienced hypersensitivity reactions symptoms were eligible for this study. Clinical symptoms of hypersensitivity reactions, population characteristics and administered chemotherapy regimens were identified. RESULTS: The hypersensitivity reactions frequency was rare (1.2%) and concerned 17 patients in our study. Typical clinical features of immediate hypersensitivity reactions associated with treatment were observed for nine patients (anaphylactic reactions for three cases, angioedema and hypotension associated with asthenia and heat in one case, respectively, and other cutaneous symptoms in the remaining four cases). Skin tests were positive in three patients, but only for platinum salts. The outcome after reintroduction of a negatively tested platinum salt allowed us to calculate a negative predictive value for platinum salt skin tests of 100%. For pemetrexed, skin tests were negative for all patients. WHAT IS NEW AND CONCLUSION: Skin tests could be used to diagnose hypersensitivity reactions with platinum salts or to evaluate the possibility of cross-reactions between two platinum salts. A negative skin test may predict with reasonable reliability the absence of future hypersensitivity reactions in case of reintroduction of drug infusion. Because the IgE-mediated mechanism has never been demonstrated for pemetrexed, skin tests are not valid and have no diagnostic value for this molecule. Because hypersensitivity reactions are potentially fatal adverse events, we recommend that patients who experience a hypersensitivity reactions onset should be monitored closely and clinicians must be aware of hypersensitivity reaction signs.


Subject(s)
Antineoplastic Agents/adverse effects , Drug Hypersensitivity/etiology , Skin Tests/methods , Antineoplastic Agents/administration & dosage , Antineoplastic Agents/immunology , Carcinoma, Non-Small-Cell Lung/drug therapy , Cross Reactions/immunology , Drug Hypersensitivity/diagnosis , Drug Hypersensitivity/immunology , Humans , Lung Neoplasms/drug therapy , Mesothelioma/drug therapy , Mesothelioma, Malignant , Pemetrexed/administration & dosage , Pemetrexed/adverse effects , Pemetrexed/immunology , Platinum Compounds/administration & dosage , Platinum Compounds/adverse effects , Platinum Compounds/immunology , Predictive Value of Tests , Reproducibility of Results , Retrospective Studies
4.
Pediatr Transplant ; 21(1)2017 Feb.
Article in English | MEDLINE | ID: mdl-27925367

ABSTRACT

In pediatric heart transplantation, the size of the donor organ is an important criterion for organ allocation. Oversized donor hearts are often accepted with good results, but some complications in relation to a high donor-recipient ratio have been described. Our patient was transplanted for progressive heart failure in dilated cardiomyopathy. The donor-to-recipient weight ratio was 3 (donor weight 65 kg, recipient weight 22 kg). The intra-operative echocardiography before chest closure showed excellent cardiac function, no tricuspid valve regurgitation, and a normal central venous pressure. After chest closure, central venous pressure increased substantially and echocardiography revealed a severe tricuspid insufficiency. As other reasons for right ventricular dysfunction, that is, myocardial ischemia, pulmonary hypertension, and rejection, were excluded, we assumed that the insufficiency was caused by an alteration of the right ventricular geometry. After 1 week, the valve insufficiency regressed to a minimal degree. In pediatric heart transplant patients with a high donor-to-recipient weight ratio, the outlined complication may occur. If other reasons for right ventricular heart failure can be ruled out, this entity is most likely caused by an acute and transient alteration of the right ventricular geometry that may disappear over time.


Subject(s)
Cardiomyopathy, Dilated/surgery , Heart Failure/surgery , Heart Transplantation , Heart/anatomy & histology , Organ Size , Tricuspid Valve Insufficiency/etiology , Body Weight , Cardiomyopathy, Dilated/physiopathology , Child , Echocardiography , Female , Heart Failure/physiopathology , Humans , Postoperative Period , Tissue Donors , Tricuspid Valve/physiopathology , Tricuspid Valve Insufficiency/complications
5.
Arthritis Care Res (Hoboken) ; 69(7): 1069-1075, 2017 07.
Article in English | MEDLINE | ID: mdl-27696784

ABSTRACT

OBJECTIVE: Sjögren's syndrome (SS) patients may be affected by the neuromyelitis optica spectrum disorder (NMOSD), a severe demyelinating syndrome associated with anti-aquaporin 4 antibodies (anti-AQP-4 antibodies). The relationship between SS and NMOSD has been a sustained focus of investigation. Among SS patients, anti-AQP-4 antibodies have been detected exclusively in those with NMOSD. It has therefore been speculated that NMOSD is not a neurologic complication of SS. However, such studies evaluated small numbers of SS patients, often mixed with other inflammatory disorders. METHODS: We compared frequencies of anti-AQP-4 and SS-associated antibodies in 109 SS patients, including 11 with NMOSD, 8 with non-NMOSD demyelinating syndromes, and 90 without demyelinating syndromes. RESULTS: When assessed using a fluorescence-activated cell sorting (FACS) assay, anti-AQP-4 antibodies were seen exclusively in those SS patients with NMOSD (72.7%), but not in SS patients without NMOSD (P < 0.01). In contrast, anti-Ro 52, anti-Ro 60, and other autoantibodies were not more prevalent in SS patients with NMOSD versus those without. Anti-AQP-4 antibodies were detected more frequently among NMOSD patients by FACS assay than with a commercial immunohistochemical assay (72.7% versus 54.5%), despite assessment after a more prolonged period of immunosuppressive therapy (median 38 months versus 5 months; P < 0.01). CONCLUSION: The syndrome-specificity of anti-AQP-4 antibodies, along with an otherwise similar antibody profile in SS NMOSD patients, indicates that NMOSD is not a direct central nervous system manifestation of SS. Anti-AQP-4 antibodies can persist and be refractory to prolonged immunosuppressive therapy.


Subject(s)
Aquaporin 4/blood , Autoimmunity/physiology , Neuromyelitis Optica/blood , Neuromyelitis Optica/epidemiology , Sjogren's Syndrome/blood , Sjogren's Syndrome/epidemiology , Adolescent , Adult , Aged , Autoantibodies/blood , Central Nervous System Diseases/blood , Central Nervous System Diseases/diagnosis , Central Nervous System Diseases/epidemiology , Cohort Studies , Comorbidity , Cross-Sectional Studies , Female , Humans , Male , Middle Aged , Neuromyelitis Optica/diagnosis , Sjogren's Syndrome/diagnosis , Young Adult
6.
Br J Anaesth ; 116(4): 546-53, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26994232

ABSTRACT

BACKGROUND: Catheter-related infections are a serious complication of continuous thoracic epidural analgesia. Tunnelling catheters subcutaneously may reduce infection risk. We thus tested the hypothesis that tunnelling of thoracic epidural catheters is associated with a lower risk of catheter-related infections. METHODS: Twenty-two thousand, four hundred and eleven surgical patients with continuous thoracic epidural analgesia included in the German Network for Regional Anaesthesia registry between 2007 and 2014 were grouped by whether their catheters were tunnelled (n=12 870) or not (n=9541). Catheter-related infections in each group were compared with Student's unpaired t and χ(2) tests. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated with logistic regression, adjusting for potential confounding factors, including age, ASA physical status score, use of catheter for ≥4 days, multiple skin puncture, hospital, and surgical department. RESULTS: There were fewer catheter-related infections in patients with tunnelled catheters (4.5 vs 5.5%, P<0.001). Mild infections were also less common (4.0 vs 4.6%, P=0.009), as were moderate infections (0.4 vs 0.8%, P<0.001). After adjustment for potential confounding factors, tunnelling remained an independent prevention for any grade of infection (adjusted OR 0.51, 95% CI 0.42-0.61, P<0.001) and for mild infections (adjusted OR 0.54, 95% CI 0.43-0.66, P<0.001) and moderate and severe infections (adjusted OR 0.44, 95% CI 0.28-0.70, P=0.001). CONCLUSION: Tunnelling was associated with a lower risk of thoracic epidural catheter-related infections.


Subject(s)
Analgesia, Epidural/adverse effects , Analgesia, Epidural/instrumentation , Catheter-Related Infections/epidemiology , Catheterization/methods , Epidural Space , Aged , Analgesia, Epidural/methods , Catheter-Related Infections/prevention & control , Catheters , Databases, Factual , Female , Humans , Male , Middle Aged , Pain/epidemiology , Pain/etiology , Patient Satisfaction , Registries , Retrospective Studies , Thoracic Vertebrae
7.
Cell Death Dis ; 6: e1791, 2015 Jun 18.
Article in English | MEDLINE | ID: mdl-26086964

ABSTRACT

Synaptic loss is one of the major features of Alzheimer's disease (AD) and correlates with the degree of dementia. N-methyl-D-aspartate receptors (NMDARs) have been shown to mediate downstream effects of the ß-amyloid peptide (Aß) in AD models. NMDARs can trigger intracellular cascades via Ca(2+) entry, however, also Ca(2+)-independent (metabotropic) functions of NMDARs have been described. We aimed to determine whether ionotropic or metabotropic NMDAR signaling is required for the induction of synaptic loss by Aß. We show that endogenous Aß as well as exogenously added synthetic Aß oligomers induced dendritic spine loss and reductions in pre- and postsynaptic protein levels in hippocampal slice cultures. Synaptic alterations were mitigated by blocking glutamate binding to NMDARs using NMDAR antagonist APV, but not by preventing ion flux with Ca(2+) chelator BAPTA or open-channel blockers MK-801 or memantine. Aß increased the activity of p38 MAPK, a kinase involved in long-term depression and inhibition of p38 MAPK abolished the loss of dendritic spines. Aß-induced increase of p38 MAPK activity was prevented by APV but not by BAPTA, MK-801 or memantine treatment highlighting the role of glutamate binding to NMDARs but not Ca(2+) flux for synaptic degeneration by Aß. We further show that treatment with the G protein inhibitor pertussis toxin (PTX) did not prevent dendritic spine loss in the presence of Aß oligomers. Our data suggest that Aß induces the activation of p38 MAPK and subsequent synaptic loss through Ca(2+) flux- and G protein-independent mechanisms.


Subject(s)
Amyloid beta-Peptides/metabolism , Calcium/metabolism , Dendritic Spines/pathology , Receptors, N-Methyl-D-Aspartate/metabolism , p38 Mitogen-Activated Protein Kinases/metabolism , Alzheimer Disease/pathology , Animals , Dizocilpine Maleate/pharmacology , Egtazic Acid/analogs & derivatives , Egtazic Acid/pharmacology , GTP-Binding Proteins/antagonists & inhibitors , Glutamic Acid/metabolism , Hippocampus/pathology , Memantine/pharmacology , Mice , Mice, Inbred C57BL , Mice, Transgenic , Neuroprotective Agents/pharmacology , Pertussis Toxin/pharmacology , Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors , Signal Transduction , Valine/analogs & derivatives , Valine/pharmacology , p38 Mitogen-Activated Protein Kinases/antagonists & inhibitors
8.
Am J Transplant ; 14(12): 2903-5, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25293954

ABSTRACT

Implementation of ABO-incompatible (ABOi) pediatric heart transplantation has contributed to significant reduction in the mortality of infants on the waiting list, without increasing the risk of rejection. This has been attributed to the immature and therefore not fully competent immune system in this population group, which results in lower production of isohemagglutinins compared to older children and adults. Serial evaluations of isohemagglutinin titers in infants revealed cases with absence of donor specific anti-blood group antibodies. However, it is currently unknown whether continuous exposure to donor antigens is necessary to prevent formation of donor specific isohemagglutinins (DSI) in recipients. We are reporting a case of an infant who underwent ABOi heart transplantation, with no evidence of DSI even 4 years after ABO-compatible retransplantation. Hence, temporary exposure to donor antigens in infants may contribute to permanent absence of donor specific anti-blood group antibodies, suggesting the possibility of induced permanent B cell tolerance.


Subject(s)
ABO Blood-Group System/immunology , Blood Group Incompatibility/immunology , Graft Rejection/immunology , Heart Diseases/surgery , Heart Transplantation , Hemagglutinins/immunology , Tissue Donors , Female , Heart Diseases/immunology , Humans , Immune Tolerance , Infant , Postoperative Complications , Prognosis , Reoperation
9.
Obes Rev ; 15 Suppl 3: 40-7, 2014 Aug.
Article in English | MEDLINE | ID: mdl-25047377

ABSTRACT

The key person for the implementation of kindergarten-based behavioural interventions is the kindergarten teacher. When conducting intervention studies in kindergartens, training sessions are needed to train and motivate kindergarten teachers for programme implementation. This paper presents the systematic development of the teachers' trainings executed in the ToyBox-intervention - a kindergarten-based and family-involved obesity prevention programme for children aged 4-6. Based on concepts for the education of kindergarten teachers, on general strategies for successful programme implementation and on the ToyBox programme-specific requirements, the aims of the teachers' trainings were defined and an overall concept was deduced. Regarding the concept for the ToyBox teachers' training sessions, it is concluded that the training modules should focus on presenting information on the practical implementation of the intervention. Furthermore, these modules should also include self-efficacy enhancing components and should give kindergarten teachers opportunities to share experiences. Regarding the didactic methods applied in the ToyBox teachers' training sessions, constructivist learning approaches that facilitate active participation, reflective thinking and personal involvement were implemented. Emphasis was put not only on the content but especially on the didactic methods of teachers' trainings in order to enhance devotion to, and quality and sustainability of the ToyBox-intervention.


Subject(s)
Faculty , Health Behavior , Motor Activity , Pediatric Obesity/prevention & control , School Health Services , Child, Preschool , Europe/epidemiology , Evidence-Based Practice , Faculty/organization & administration , Female , Health Knowledge, Attitudes, Practice , Humans , Male , Motivation , Multicenter Studies as Topic , Needs Assessment , Pediatric Obesity/epidemiology , Play and Playthings , Program Development , Program Evaluation , Randomized Controlled Trials as Topic , Sedentary Behavior , Social Environment
10.
Obes Rev ; 15 Suppl 3: 48-52, 2014 Aug.
Article in English | MEDLINE | ID: mdl-25047378

ABSTRACT

Since school-based interventions are mainly delivered by the school staff, they need to be well-trained and familiarized with the programme's aims, procedures and tools. Therefore, the institute, research group, governmental or non-governmental body in charge of the coordination and implementation of the programme needs to devote time and resources to train the school staff before programme's implementation. This is particularly crucial in multi-centre studies where more than one research teams are involved. Both research teams and school staff need to be trained, using standard protocols and procedures, to ensure that the intervention will be delivered in a standardized manner throughout the intervention centres. The ToyBox-intervention, a multi-component, kindergarten-based, family-involved intervention, focusing on water consumption, snacking, physical activity and sedentary behaviours in preschool children, was implemented over the academic year 2012-2013 in six European countries. As part of this intervention, three teachers' training sessions were delivered to motivate and train teachers in implementing the intervention. The local researchers were trained centrally before delivering the training sessions for the teachers and followed a common protocol using standardized presentations and procedures. The aim of the current paper is to describe the protocol and methodological issues related to the teachers' training sessions conducted within the ToyBox-intervention.


Subject(s)
Faculty , Health Behavior , Motor Activity , Pediatric Obesity/prevention & control , School Health Services , Child, Preschool , Europe/epidemiology , Evidence-Based Practice , Faculty/organization & administration , Female , Health Knowledge, Attitudes, Practice , Humans , Male , Menu Planning/methods , Motivation , Multicenter Studies as Topic , Pediatric Obesity/epidemiology , Play and Playthings , Program Development , Program Evaluation , Randomized Controlled Trials as Topic , Sedentary Behavior , Social Environment
11.
Obes Rev ; 15 Suppl 3: 61-6, 2014 Aug.
Article in English | MEDLINE | ID: mdl-25047380

ABSTRACT

Reliable assessments of health-related behaviours are necessary for accurate evaluation on the efficiency of public health interventions. The aim of the current study was to examine the reliability of a self-administered primary caregivers questionnaire (PCQ) used in the ToyBox-intervention. The questionnaire consisted of six sections addressing sociodemographic and perinatal factors, water and beverages consumption, physical activity, snacking and sedentary behaviours. Parents/caregivers from six countries (Belgium, Bulgaria, Germany, Greece, Poland and Spain) were asked to complete the questionnaire twice within a 2-week interval. A total of 93 questionnaires were collected. Test-retest reliability was assessed using intra-class correlation coefficient (ICC). Reliability of the six questionnaire sections was assessed. A stronger agreement was observed in the questions addressing sociodemographic and perinatal factors as opposed to questions addressing behaviours. Findings showed that 92% of the ToyBox PCQ had a moderate-to-excellent test-retest reliability (defined as ICC values from 0.41 to 1) and less than 8% poor test-retest reliability (ICC < 0.40). Out of the total ICC values, 67% showed good-to-excellent reliability (ICC from 0.61 to 1). We conclude that the PCQ is a reliable tool to assess sociodemographic characteristics, perinatal factors and lifestyle behaviours of pre-school children and their families participating in the ToyBox-intervention.


Subject(s)
Diet , Health Behavior , Motor Activity , Parents , Pediatric Obesity/prevention & control , School Health Services , Caregivers/education , Caregivers/psychology , Child, Preschool , Europe/epidemiology , Evidence-Based Medicine , Female , Health Knowledge, Attitudes, Practice , Humans , Life Style , Male , Multicenter Studies as Topic , Parents/education , Parents/psychology , Pediatric Obesity/psychology , Play and Playthings , Program Development , Program Evaluation , Randomized Controlled Trials as Topic , Reproducibility of Results , Self Report , Surveys and Questionnaires
12.
Obes Rev ; 15 Suppl 3: 74-80, 2014 Aug.
Article in English | MEDLINE | ID: mdl-25047382

ABSTRACT

Process evaluation (PE) is used for the in-depth evaluation of the implementation process of health promotion programmes. The aim of the current paper was to present the PE design and tools used in the ToyBox-intervention. The PE design was based on a three-step approach, including the identification of ToyBox-specific PE elements (step 1), the development of PE tools and harmonization of procedures (step 2), and the implementation of PE using standardized protocol and tools across the intervention countries (step 3). Specifically, to evaluate the implementation of the intervention, teachers' monthly logbooks were recorded (dose delivered, fidelity, dose received); post-intervention questionnaires were completed by parents/caregivers and teachers (dose received); participation and attrition rates were recorded (recruitment, reach); and audit questionnaires and retrospective information on weather conditions were collected (physical and social environment within which the intervention was implemented). Regarding the teachers' training sessions, the researchers who performed the trainings completed evaluation forms and documented teachers' attendance after each training (dose delivered, fidelity, dose received) and teachers completed evaluation forms after each training (dose received). The PE performed in the ToyBox-intervention may contribute in the evaluation of its effectiveness, guide the revision of the intervention material and provide insights for future health promotion programmes and public health policy.


Subject(s)
Pediatric Obesity/prevention & control , School Health Services , Child, Preschool , Diet , Europe/epidemiology , Evidence-Based Medicine , Female , Health Knowledge, Attitudes, Practice , Humans , Life Style , Male , Motor Activity , Multicenter Studies as Topic , Parents , Pediatric Obesity/psychology , Program Development , Program Evaluation , Randomized Controlled Trials as Topic , Reference Standards , Reproducibility of Results , Self Report , Social Environment , Surveys and Questionnaires
13.
Obes Rev ; 15 Suppl 3: 81-9, 2014 Aug.
Article in English | MEDLINE | ID: mdl-25047383

ABSTRACT

Overweight and obesity in children are recognized as a major health problem. The ToyBox-intervention was developed with the aim of preventing obesity in pre-schoolers. Because it is increasingly important to inform policy makers not only on the effects of prevention interventions, but also on their costs and cost-effectiveness, our purpose was to establish a method to estimate the cost-effectiveness of the ToyBox-intervention. In order to estimate the long-term impact of the ToyBox-intervention on health and societal costs, extrapolations of the intervention effect will be conducted to predict children's weight status (based on the body mass index) at adult age. Effects of the adult weight status on the prevalence of obesity-related complications will be modelled through a Markov model, with a total time horizon of 70 years and a cycle length of 1 year. The model will be conducted in six European countries participating in the ToyBox-intervention, based on country-specific economic and epidemiological data. This study describes the methodological rationale and implementation of an analytic model to examine the cost-effectiveness of the ToyBox-intervention for six European countries, in order to inform decision-makers on the value for money of this intervention in the prevention of obesity in pre-schoolers.


Subject(s)
Cost-Benefit Analysis/methods , Pediatric Obesity/prevention & control , Program Development/economics , School Health Services , Child, Preschool , Diet , Europe/epidemiology , Evidence-Based Medicine , Female , Health Knowledge, Attitudes, Practice , Humans , Life Style , Male , Markov Chains , Models, Economic , Motor Activity , Multicenter Studies as Topic , Parents , Pediatric Obesity/complications , Pediatric Obesity/psychology , Program Evaluation , Randomized Controlled Trials as Topic , Reproducibility of Results , Social Environment , Surveys and Questionnaires
14.
Arthritis Rheumatol ; 66(4): 1000-9, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24757151

ABSTRACT

OBJECTIVE: To characterize peripheral neuropathy subtypes, ancillary studies, and immunologic profiles associated with peripheral neuropathies in patients with systemic lupus erythematosus (SLE). METHODS: In this 25-year study of 2,097 SLE patients, we characterized peripheral neuropathies due to SLE and compared clinical and SLE-related features in patients with versus those without neuropathy. RESULTS: The prevalence of peripheral neuropathies was 5.9% (123 of 2,097 patients), and 66.7% of these patients (82 of 123) had peripheral neuropathies attributable to SLE. We noted that 17.1% of the patients with peripheral neuropathies due to SLE (14 of 82 patients) had small-fiber neuropathy, which is a painful neuropathy not included in the American College of Rheumatology (ACR) neuropsychiatric SLE (NPSLE) case definitions. SLE patients with small-fiber neuropathies could present with unorthodox neuropathic pain patterns not consistent with a stocking-glove distribution and had associated skin biopsy results suggestive of dorsal root ganglion neuronal cell loss. Compared to SLE patients without peripheral neuropathies, those with peripheral neuropathies had lower mean disease activity (P = 0.01) and higher disease damage (P < 0.01) and were more likely to have a history of herpes zoster virus infection (P < 0.01), osteoporotic fractures (P < 0.01), and opportunistic infections (P < 0.01). CONCLUSION: Our findings indicate that small-fiber neuropathy is a frequently occurring peripheral neuropathy. The skin biopsy findings in small-fiber neuropathy patients support the notion that distinct mechanisms target the dorsal root ganglia as well as distal axons. SLE patients with peripheral neuropathy have lower mean disease activity scores and higher disease damage. Our findings suggest that revision of the ACR NPSLE case definitions, which currently do not include small-fiber neuropathies, is warranted.


Subject(s)
Demyelinating Diseases/etiology , Lupus Erythematosus, Systemic/complications , Peripheral Nervous System Diseases/etiology , Adult , Aged , Demyelinating Diseases/epidemiology , Demyelinating Diseases/pathology , Female , Ganglia, Spinal/pathology , Humans , Lupus Erythematosus, Systemic/epidemiology , Lupus Erythematosus, Systemic/pathology , Male , Middle Aged , Nerve Fibers/pathology , Peripheral Nervous System Diseases/epidemiology , Peripheral Nervous System Diseases/pathology , Prevalence , Skin/innervation , Skin/pathology
15.
Clin Exp Allergy ; 42(9): 1406-15), 2012 Sep.
Article in English | MEDLINE | ID: mdl-22747483

ABSTRACT

OBJECTIVE: To establish the prevalence and serum levels of IgE to commercial Der p 1, Der p 2, Der p 10 and the carbohydrate MUXF3 in house dust-mite allergic patients. To compare individual vs. allergen microarray methods. METHODS: Prevalence and serum levels of IgE to Dermatophagoides pteronyssinus extract and components Der p 1, Der p 2, Der p 10 and MUXF3, specific IgG4 to D. pteronyssinus, total serum IgE levels, and clinical features (age, asthma, rhinitis and atopic dermatitis) were determined in 123 patients (64 children) with the ImmunoCAP® method. ImmunoCAP ISAC® was performed in 24 patients. RESULTS: All patients had serum IgE to D. pteronyssinus. Prevalences of serum IgE to commercial components were Der p 1 93%, Der p 2 77% (Der p 1 or Der p 2 94%), Der p 10 28% and MUXF3 25%. Levels of D. pteronyssinus IgE strongly correlated with Der p 1 and Der p 2 IgE (r = 0.89 and 0.85 respectively), but not Der p 10 and MUXF3. ImmunoCAP® and ImmunoCAP ISAC® were concordant, but the quantitative correlation was poor. No clinical implication for the prevalence, levels, or molecular IgE reactivity profile to house dust mite components was found. CONCLUSIONS AND CLINICAL RELEVANCE: Commercially available Der p 1 and Der p 2 strongly correlate with IgE D. pteronyssinus. The lack of Der p 1 and Der p 2 IgE may help with differential diagnosis. Der p 10 serum IgE prevalence and levels suggest different patterns in food and mite-related tropomyosin sensitization. Serum IgE to carbohydrate MUXF3, although unexpectedly prevalent, were low and did not modify D. pteronyssinus IgE levels. Follow-up may be best carried out with individual rather than microarrayed components.


Subject(s)
Antigens, Dermatophagoides/immunology , Arthropod Proteins/immunology , Cysteine Endopeptidases/immunology , Hypersensitivity, Immediate/diagnosis , Pyroglyphidae/immunology , Tropomyosin/immunology , Adolescent , Adult , Aged , Aged, 80 and over , Animals , Asthma/diagnosis , Asthma/immunology , Child , Child, Preschool , Dermatitis, Atopic/diagnosis , Dermatitis, Atopic/immunology , Dermatophagoides pteronyssinus/immunology , Female , Humans , Hypersensitivity, Immediate/etiology , Hypersensitivity, Immediate/immunology , Immunoglobulin E/blood , Immunoglobulin G/blood , Male , Middle Aged , Reagent Kits, Diagnostic , Rhinitis, Allergic, Perennial/diagnosis , Rhinitis, Allergic, Perennial/immunology , Young Adult
16.
Schmerz ; 25(1): 62-8, 2011 Feb.
Article in German | MEDLINE | ID: mdl-21258820

ABSTRACT

BACKGROUND: Levobupivacaine and ropivacaine are both used for continuous femoral analgesia after anterior cruciate ligament reconstruction; however it is unknown whether both drugs are equally effective regarding pain control, preservation of mobility and patient satisfaction. METHODS AND MATERIALS: In this randomized, placebo-controlled trial 84 patients undergoing anterior cruciate ligament (ACL) reconstruction with quadruple hamstring tendons were studied. For postoperative pain therapy levobupivacaine 0.125%, ropivacaine 0.2% or placebo control with NaCl 0.9% at a rate of 6 ml/h were used for 48 h using a femoral nerve catheter. All patients also received an i.v. patient-controlled analgesia (IVPCA) pump with piritramide. RESULTS: Patient satisfaction was significantly higher and night rest was better in both treatment groups compared to the placebo group but there appeared to be no major differences between the two local anesthetics. Opioid consumption was significantly higher in the placebo group compared to the levobupivacaine group but not the ropivacaine group. The pain scores showed a trend towards higher scores in the placebo group throughout but the difference only reached statistical significance on postoperative day 1. No statistical significant differences in motor block were found between the three groups. CONCLUSION: Postoperative analgesia for ACL reconstruction during the first 48 h using femoral block with a continuous infusion of levobupivacaine 0.125% or ropivacaine 0.2% in combination with an IVPCA is similarly effective and better than a placebo. Both studied drugs seem to be equally appropriate for this purpose.


Subject(s)
Amides , Anesthetics, Local , Anterior Cruciate Ligament Injuries , Anterior Cruciate Ligament/surgery , Knee Injuries/surgery , Nerve Block/methods , Pain, Postoperative/drug therapy , Adult , Analgesia, Patient-Controlled , Analgesics, Opioid/therapeutic use , Bupivacaine/analogs & derivatives , Catheters, Indwelling , Double-Blind Method , Female , Femoral Nerve/drug effects , Humans , Levobupivacaine , Male , Middle Aged , Pain Measurement/drug effects , Patient Satisfaction , Pirinitramide/therapeutic use , Ropivacaine , Tendon Transfer , Young Adult
17.
Am J Transplant ; 10(1): 149-56, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19951279

ABSTRACT

Specific B-cell tolerance toward donor blood group antigens develops in infants after ABO-incompatible heart transplantation, whereas their immune response toward protein antigens such as HLA has not been investigated. We assessed de novo HLA-antibodies in 122 patients after pediatric thoracic transplantation (28 ABO-incompatible) and 36 controls. Median age at transplantation was 1.7 years (1 day to 17.8 year) and samples were collected at median 3.48 years after transplantation. Antibodies were detected against HLA-class I in 21 patients (17.2%), class II in 18 (14.8%) and against both classes in 10 (8.2%). Using single-antigen beads, donor-specific antibodies (DSAs) were identified in six patients (all class II, one additional class I). Patients with DSAs were significantly older at time of transplantation. In patients who had undergone pretransplant cardiac surgeries, class II antibodies were more frequent, although use of homografts or mechanical heart support had no influence. DSAs were absent in ABO-incompatible recipients and class II antibodies were significantly less frequent than in children with ABO-compatible transplants. This difference was present also when comparing only children transplanted below 2 years of age. Therefore, tolerance toward the donor blood group appears to be associated with an altered response to HLA beyond age-related effects.


Subject(s)
HLA Antigens/immunology , Heart Transplantation/immunology , Isoantibodies/blood , ABO Blood-Group System , Adolescent , Age Factors , Blood Grouping and Crossmatching , Case-Control Studies , Child , Child, Preschool , Female , Graft Survival/immunology , HLA-D Antigens/immunology , Histocompatibility Antigens Class I/immunology , Histocompatibility Testing , Humans , Infant , Infant, Newborn , Male , Risk Factors , Tissue Donors
18.
Arthritis Rheum ; 60(11): 3378-87, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19877037

ABSTRACT

OBJECTIVE: Myelitis causes pain, weakness, and sphincteric deficits, and is 1,000-fold more prevalent in patients with systemic lupus erythematosus (SLE) than in the general population. For the last century, descriptions of SLE myelitis have been primarily limited to case reports. In contrast, larger-scale cohort studies have revealed that myelitis occurring in the idiopathic demyelinating diseases (i.e., multiple sclerosis versus neuromyelitis optica) represents distinct syndromes. This study was undertaken to determine whether SLE myelitis similarly encapsulates distinct syndromes. METHODS: We analyzed a cohort of 22 patients with SLE and myelitis. Patients were assessed for neurologic variables related to myelitis and for clinical and serologic features of SLE. Magnetic resonance images of the spine, cerebrospinal fluid profiles, and autoantibody profiles were obtained. RESULTS: Eleven patients presented with signs of gray matter dysfunction (i.e., flaccidity and hyporeflexia), whereas 11 patients presented with signs of white matter dysfunction (i.e., spasticity and hyperreflexia). Patients with gray matter dysfunction were more likely to have irreversible paraplegia (P < 0.01), despite presenting with a monophasic versus polyphasic course (P = 0.01), higher levels of SLE activity (mean SLE Disease Activity Index 9.8 versus 2.0; P = 0.01), and a cerebrospinal fluid profile indistinguishable from bacterial meningitis. Prior to irreversible paraplegia, these patients presented with prodromes of fever and urinary retention, but were misdiagnosed by physicians of different specialties as having urinary tract infections. Patients with white matter dysfunction were more likely to meet criteria for neuromyelitis optica (P = 0.04) and were also more likely to have antiphospholipid antibodies (lupus anticoagulant) (P = 0.01). CONCLUSION: Our findings indicate that SLE myelitis encapsulates 2 distinct and previously unrecognized syndromes that can be distinguished clinically by gray matter versus white matter findings. Recognition of fever and urinary retention as prodromes of irreversible paraplegia may allow earlier diagnosis and treatment in SLE patients presenting with gray matter findings.


Subject(s)
Lupus Erythematosus, Systemic/complications , Myelitis, Transverse/etiology , Severity of Illness Index , Adolescent , Adult , Aged , Autonomic Dysreflexia/etiology , Autonomic Dysreflexia/pathology , Cohort Studies , Female , Humans , Lupus Erythematosus, Systemic/diagnosis , Lupus Erythematosus, Systemic/pathology , Magnetic Resonance Imaging , Male , Middle Aged , Muscle Hypotonia/etiology , Muscle Hypotonia/pathology , Muscle Spasticity/etiology , Muscle Spasticity/pathology , Myelitis, Transverse/pathology , Paraplegia/etiology , Paraplegia/pathology , Prognosis , Retrospective Studies , Spine/pathology , Syndrome , Young Adult
19.
Anaesthesist ; 58(10): 986-91, 2009 Oct.
Article in German | MEDLINE | ID: mdl-19629398

ABSTRACT

BACKGROUND: The use of nerve stimulation is a common standard procedure for peripheral nerve blocks. However, ultrasound guidance is increasingly being used as an alternative. This study explored the relationship between needle positioning defined by ultrasound guidance and the electrical nerve stimulation before and after injection of 5% glucose solution (G5%). PATIENTS AND METHODS: After obtaining permission from the ethics committee, 60 patients were enrolled in the study and the results from 51 patients could be analyzed. For sonographically defined correct needle placement the lowest electrical threshold of the elicited motor responses before and after injection of 1 ml G5% was determined. RESULTS: In 76% of cases nerve structures could be visualized with high quality and 90% of the blocks were successful. Only 29% of patients with a successful block showed a motor response with a stimulation current < or = 0.5 mA. There was a relationship only between the quality of the visualization and the success of the blockade. Addition of G5% did not result in significant changes in stimulation thresholds. CONCLUSION: With the protocol used the success of a blockade depends only on the quality of visualization. With correct ultrasound-guided needle tip positioning the electrical information seems to be skewed and doubtful.


Subject(s)
Electric Stimulation , Glucose Solution, Hypertonic/pharmacology , Nerve Block/methods , Ultrasonography/methods , Adult , Aged , Aged, 80 and over , Brachial Plexus/diagnostic imaging , Brachial Plexus/surgery , Female , Humans , Male , Middle Aged , Movement/drug effects , Needles , Pain Measurement , Peripheral Nerves/diagnostic imaging , Peripheral Nerves/surgery , Young Adult
20.
J Int Med Res ; 36(4): 748-59, 2008.
Article in English | MEDLINE | ID: mdl-18652771

ABSTRACT

We determined the effects of combinations of C1 esterase inhibitor (C1-INH) with factor XIII and of N-acetylcysteine (NAC) with tirilazad mesylate (TM) during lipo-polysaccharide (LPS)-induced endotoxaemia in rats. Forty Wistar rats were divided into four groups: the control (CON) group received no LPS; the LPS, C1-INH + factor XIII and NAC + TM groups received endotoxin infusions (5 mg/kg per h). After 30 min of endotoxaemia, 100 U/kg C1-INH + 50 U/kg factor XIII was administered to the C1-INH + factor XIII group, and 150 mg/kg NAC + 10 mg/kg TM was administered in the NAC + TM group. Administration of C1-INH + factor XIII and NAC + TM both resulted in reduced leucocyte adherence and reduced levels of interleukin-1beta (IL-1beta). The LPS-induced increase in IL-6 levels was amplified by both drug combinations. There was no significant effect on mesenteric plasma extravasation. In conclusion, the administration of C1-INH + factor XIII and NAC + TM reduced endothelial leucocyte adherence and IL-1beta plasma levels, but increased IL-6 levels.


Subject(s)
Acetylcysteine/therapeutic use , Complement C1 Inhibitor Protein/therapeutic use , Cytokines/blood , Endotoxemia , Factor XIII/therapeutic use , Leukocytes/metabolism , Pregnatrienes/therapeutic use , Animals , Antioxidants/therapeutic use , Cell Adhesion/physiology , Cytokines/immunology , Drug Therapy, Combination , Endothelium, Vascular/cytology , Endothelium, Vascular/metabolism , Endotoxemia/drug therapy , Endotoxemia/immunology , Humans , Leukocytes/cytology , Male , Random Allocation , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL
...